Shockwave Medical rises after Johnson & Johnson agrees to $12.5 bln deal
** Shares of medical device maker Shockwave Medical SWAV.O
rise 1.1% to $323.60 premarket
** Johnson & Johnson JNJ.N says it will buy SWAV in a
$12.5 bln deal
** JNJ to pay $335 per share in cash, implying a 4.7%
premium to SWAV's last close of $319.99 on Thursday
** Shares have risen 11.4% since a report of deal talks
emerged on March 26
** Up to last close, stock up 67.9% YTD
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
Recent news on Shockwave Medical
See all newsSarepta Therapeutics gains on S&P MidCap inclusion
Brief: Sarepta Therapeutics Set To Join S&P Midcap 400
Brief: Shockwave Medical Required Waiting Period For Johnson & Johnson Merger Expired On May 20
Shockwave Medical Inc reports results for the quarter ended in January - Earnings Summary
Brief: Shockwave Medical Q1 EPS USD 1.44